[HTML][HTML] PPARγ and TGFβ—major regulators of metabolism, inflammation, and fibrosis in the lungs and kidneys
G Kökény, L Calvier, G Hansmann - International journal of molecular …, 2021 - mdpi.com
Peroxisome proliferator-activated receptor gamma (PPARγ) is a type II nuclear receptor,
initially recognized in adipose tissue for its role in fatty acid storage and glucose metabolism …
initially recognized in adipose tissue for its role in fatty acid storage and glucose metabolism …
[HTML][HTML] Reelin through the years: From brain development to inflammation
Reelin was originally identified as a regulator of neuronal migration and synaptic function,
but its non-neuronal functions have received far less attention. Reelin participates in organ …
but its non-neuronal functions have received far less attention. Reelin participates in organ …
[HTML][HTML] Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
SR Joshi, J Liu, T Bloom, E Karaca Atabay, TH Kuo… - Scientific reports, 2022 - nature.com
Sotatercept is an activin receptor type IIA-Fc (ActRIIA-Fc) fusion protein that improves
cardiopulmonary function in patients with pulmonary arterial hypertension (PAH) by …
cardiopulmonary function in patients with pulmonary arterial hypertension (PAH) by …
Interplay of low-density lipoprotein receptors, LRPs, and lipoproteins in pulmonary hypertension
The low-density lipoprotein receptor (LDLR) gene family includes LDLR, very LDLR, and
LDL receptor–related proteins (LRPs) such as LRP1, LRP1b (aka LRP-DIT), LRP2 (aka …
LDL receptor–related proteins (LRPs) such as LRP1, LRP1b (aka LRP-DIT), LRP2 (aka …
[HTML][HTML] Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543
X Yi, X Tang, T Li, L Chen, H He, X Wu, C Xiang… - Biomedicine & …, 2023 - Elsevier
PF-543 is a sphingosine kinase 1 (SPHK1) inhibitor developed by Pfizer and is currently
considered the most potent selective SPHK1 inhibitor. SPHK1 catalyses the production of …
considered the most potent selective SPHK1 inhibitor. SPHK1 catalyses the production of …
[HTML][HTML] Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 cases
Thromboembolic complications and excessive inflammation are frequent in severe COVID-
19, potentially leading to long COVID. In non-COVID studies, we and others demonstrated …
19, potentially leading to long COVID. In non-COVID studies, we and others demonstrated …
Apolipoprotein E receptor 2 deficiency decreases endothelial adhesion of monocytes and protects against autoimmune encephalomyelitis
Under normal conditions, the blood-brain barrier effectively regulates the passage of
immune cells into the central nervous system (CNS). However, under pathological …
immune cells into the central nervous system (CNS). However, under pathological …
Reelin depletion protects against atherosclerosis by decreasing vascular adhesion of leukocytes
L Calvier, X Xian, RG Lee, A Sacharidou… - … , and vascular biology, 2021 - Am Heart Assoc
Objective: Reelin and its receptor Apoer2 (apolipoprotein E receptor 2) play a prominent role
in endothelial cell dysfunction by promoting leukocyte–endothelial cell adhesion, an …
in endothelial cell dysfunction by promoting leukocyte–endothelial cell adhesion, an …
[HTML][HTML] Cellular mechanosignaling in pulmonary arterial hypertension
A Wang, D Valdez-Jasso - Biophysical reviews, 2021 - Springer
Pulmonary arterial hypertension (PAH) is a vasculopathy characterized by sustained
elevated pulmonary arterial pressures in which the pulmonary vasculature undergoes …
elevated pulmonary arterial pressures in which the pulmonary vasculature undergoes …
[HTML][HTML] Soluble Receptor for Advanced Glycation End Products (sRAGE) is a sensitive biomarker in human pulmonary arterial hypertension
F Diekmann, P Chouvarine, H Sallmon… - International Journal of …, 2021 - mdpi.com
Pulmonary arterial hypertension (PAH) is a progressive condition with an unmet need for
early diagnosis, better monitoring, and risk stratification. The receptor for advanced glycation …
early diagnosis, better monitoring, and risk stratification. The receptor for advanced glycation …